Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China · Delayed Price · Currency is CNY 24.93
+0.38 (1.55%)
At close: Aug 4, 2026
SHE:301258 Market Cap
SHE:301258 has a market cap or net worth of 2.21 billion as of August 4, 2026. Its market cap has decreased by -30.85% in one year.
Market Cap
2.21B
Enterprise Value
1.04B
Revenue
412.51M
Ranking
n/a
PE Ratio
59.71
Stock Price
24.93
ChartMarket Cap Chart
Since March 29, 2022, SHE:301258's market cap has decreased from 6.10B to 2.21B, a decrease of -63.78%. That is a compound annual growth rate of -20.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 2.21B | -24.22% |
| Dec 31, 2025 | 2.91B | 35.37% |
| Dec 31, 2024 | 2.15B | -27.24% |
| Dec 29, 2023 | 2.96B | -17.76% |
| Dec 30, 2022 | 3.60B | -41.00% |
| Mar 29, 2022 | 6.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Landfar Bio-medicine | 2.50B |
| Shanghai Model Organisms Center | 2.47B |
| Novoprotein Scientific | 2.45B |
| Shandong Sito Bio-technology | 2.25B |
| Jilin Jian Yisheng Pharmaceutical | 2.14B |
| Shanghai Universal Biotech | 2.14B |
| Shanghai Hile Bio-Technology | 1.86B |
| Jiangsu CoWin Biotech | 1.85B |